|
US 12,234,223 B2 |
|
| Phthalazinone compound, and preparation method therefor and medical use thereof |
| Hongfu Lu, Shanghai (CN); Weiqiang Xing, Shanghai (CN); Yongcong Lv, Shanghai (CN); Baojian Qi, Shanghai (CN); Jianbiao Peng, Shanghai (CN); and Haibing Guo, Shanghai (CN) |
| Assigned to SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD., Shanghai (CN); and JIANGXI JEMINCARE GROUP CO., LTD, Jiangxi (CN) |
| Filed by SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD, Shanghai (CN); and JIANGXI JEMINCARE GROUP CO., LTD, Jiangxi (CN) |
| Filed on Aug. 14, 2024, as Appl. No. 18/804,443. |
| Application 18/804,443 is a continuation of application No. 18/079,778, filed on Dec. 12, 2022. |
| Application 18/079,778 is a continuation of application No. PCT/CN2021/099654, filed on Jun. 11, 2021. |
| Claims priority of application No. 202010536221.6 (CN), filed on Jun. 12, 2020; application No. 202011147078.8 (CN), filed on Oct. 23, 2020; application No. 202011261665.X (CN), filed on Nov. 12, 2020; application No. 202110485680.0 (CN), filed on Apr. 30, 2021; and application No. 202110614030.1 (CN), filed on Jun. 2, 2021. |
| Prior Publication US 2024/0400540 A1, Dec. 5, 2024 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. C07D 401/14 (2006.01); A61K 31/502 (2006.01); A61K 31/506 (2006.01); A61K 31/55 (2006.01); A61P 5/26 (2006.01); A61P 13/08 (2006.01); A61P 15/14 (2006.01); A61P 21/00 (2006.01); A61P 35/00 (2006.01); A61P 35/04 (2006.01); C07D 471/04 (2006.01); C07D 487/08 (2006.01) |
